SLAMF1 Antikörper (AA 296-325)

Produktnummer ABIN358048

Produktdetails anti-SLAMF1 Antikörper

Target: SLAMF1 (Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1))

Bindungsspezifität: AA 296-325

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SLAMF1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Enzyme Immunoassay (EIA)

Spezifität: This antibody detects CD150/SLAMF1.

Aufreinigung: Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.

Immunogen: This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 296~325 amino acids surrounding Y307 of Human SLAMF1.

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: ELISA: 1/1,000. Western Blot: 1/50-1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.25 mg/mL

Buffer: PBS with 0.09 % (W/V) Sodium Azide as preservative.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.

Details zu SLAMF1

Target: SLAMF1 (Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1))

Andere Bezeichnung: CD150 / SLAMF1 (SLAMF1 Produkte)

Synonyme: CD150 antikoerper, SLAM antikoerper, SLAMF1 antikoerper, 4933415F16 antikoerper, AA177906 antikoerper, CDw150 antikoerper, ESTM51 antikoerper, IPO-3 antikoerper, Slam antikoerper, RGD1560634 antikoerper, signaling lymphocytic activation molecule family member 1 antikoerper, SLAMF1 antikoerper, Slamf1 antikoerper

Hintergrund: SLAMF1 is high-affinity self-ligand important in bidirectional T-cell to B-cell stimulation. SLAM-induced signal-transduction events in T-lymphocytes are different from those in B-cells. Two modes of SLAM signaling are likely to exist: one in which the inhibitor SH2D1A acts as a negative regulator and another in which protein-tyrosine phosphatase 2C (PTPN11)-dependent signal transduction operates.Synonyms: CDw150, Ipo-3, Signaling lymphocytic activation molecule, Slam

Molekulargewicht: 37231 Da

Gen-ID: 6504, 9606

UniProt: Q13291